These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9540046)

  • 21. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
    McCall KL; Craddock D; Edwards K
    Pharmacotherapy; 2006 Sep; 26(9):1297-306. PubMed ID: 16945052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ACE inhibitors, yes or no?].
    Jenssen TG
    Tidsskr Nor Laegeforen; 1995 Oct; 115(24):3014-5. PubMed ID: 7570527
    [No Abstract]   [Full Text] [Related]  

  • 23. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
    Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes.
    Pedersen-Bjergaard U; Dhamrait SS; Sethi AA; Frandsen E; Nordestgaard BG; Montgomery HE; Pramming S; Hougaard P; Thorsteinsson B
    Am J Med; 2008 Mar; 121(3):246.e1-8. PubMed ID: 18328310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk in patients with type 2 diabetes.
    Shanks M; Holmes DT; Cermakova L; Frohlich J
    CMAJ; 2005 Apr; 172(9):1160-1. PubMed ID: 15851694
    [No Abstract]   [Full Text] [Related]  

  • 26. ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease.
    Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):234-9. PubMed ID: 11881030
    [No Abstract]   [Full Text] [Related]  

  • 27. Diabetes mellitus: Relevance to dental treatment.
    Vernillo AT
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):263-70. PubMed ID: 11250621
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetes, hypertension, and renal insufficiency in post-myocardial infarction cardiovascular risk.
    Abraham WT
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S30-6. PubMed ID: 14564232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Severe hypoglycemia secondary to angiotensin-converting-enzyme inhibitors in the absence of diabetes mellitus. Report of a case].
    Elorriaga-Sánchez F; Corrales-Bobadilla H; Sosa-Trinidad E; Domínguez-Quezada B
    Gac Med Mex; 2001; 137(3):249-52. PubMed ID: 11432094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of the patient with diabetes mellitus and risk of nephropathy: what do we know, and what do we need to learn?
    Hollenberg NK
    Arch Intern Med; 2004 Jan; 164(2):125-30. PubMed ID: 14744834
    [No Abstract]   [Full Text] [Related]  

  • 31. ACE inhibitors and high-risk patients.
    Myers KA
    CMAJ; 2000 Aug; 163(3):327. PubMed ID: 10951738
    [No Abstract]   [Full Text] [Related]  

  • 32. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

  • 33. [Poor control of risk factors prior to heart surgery. High proportion of undiscovered diabetes, undertreated hypertension and hyperlipidemia].
    Anderson RE; Brismar K; Lindberg A; Hylander S; Alserius T; Ivert T
    Lakartidningen; 2007 Mar 21-27; 104(12):936-40. PubMed ID: 17469307
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
    Palmer BF
    Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When hypertension and diabetes coexist: strategies for cardiorenal protection.
    Weber MA
    Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.
    Abuissa H; Jones PG; Marso SP; O'Keefe JH
    J Am Coll Cardiol; 2005 Sep; 46(5):821-6. PubMed ID: 16139131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].
    de Jong-van den Berg LT; Bakker MK; de Walle HE; van den Berg PB
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2222-3. PubMed ID: 17061436
    [No Abstract]   [Full Text] [Related]  

  • 38. ACE inhibition and renovascular disease.
    Carr S
    Diabet Med; 2001 Jan; 18 Suppl 1():4-6. PubMed ID: 11289190
    [No Abstract]   [Full Text] [Related]  

  • 39. Meeting on diabetic complications and early treatment using ACE inhibitors.
    Barnett AH; Agardh CD
    J Diabetes Complications; 1996; 10(3):124-4. PubMed ID: 8924719
    [No Abstract]   [Full Text] [Related]  

  • 40. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors.
    Morimoto T; Gandhi TK; Fiskio JM; Seger AC; So JW; Cook EF; Fukui T; Bates DW
    J Eval Clin Pract; 2004 Nov; 10(4):499-509. PubMed ID: 15482412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.